Vanguard Global Advisers’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
Other funds holding TYRA
SL
Vanguard Global Advisers's TYRA Position: Q3 2026 in Review
Vanguard Global Advisers reduced its Tyra Biosciences (TYRA) stake by 16% in Q3 2026, selling an estimated $89K and leaving 16,918 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #2229.
Vanguard Global Advisers first reported a position in TYRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $644K in Q2 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.
- Vanguard Global Advisers held 16,918 shares of Tyra Biosciences worth $370K as of Q3 2026.
- Vanguard Global Advisers sold 3,236 Tyra Biosciences shares in Q3 2026, an estimated $89K.
- Tyra Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2229 holding.
- Vanguard Global Advisers first reported a position in Tyra Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Tyra Biosciences position peaked at $644K in Q2 2026.
- 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.